Effects of immunisation against PCSK9 in mice bearing melanoma.
Conclusions: The nanoliposomal PCSK9 vaccine did not adversely affect the growth of melanoma tumour nor the survival of tumour-bearing mice.
PMID: 32051723 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Cancer Vaccines | Cholesterol | General Medicine | Melanoma | Nanotechnology | Science | Skin Cancer | Study | Vaccines